Evaluating the Efficacy of Home-Based tDCS for Cancer-Related Cognitive Impairment and Its Moderation by Obesity: A Double-Blind Randomized Controlled Trial.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this intervention is to investigate whether transcranial Direct Current Stimulation (tDCS) can alleviate Cancer-Related Cognitive Impairment (CRCI) in breast cancer survivors, as measured by changes in brain structures and cognitive performance. To assess the efficacy of tDCS, the investigators will compare outcomes between participants receiving active stimulation and those receiving sham stimulation (a placebo condition where participants believe they are receiving stimulation, but are not). Participants will: * Undergo a baseline MRI session * Receive either active or sham tDCS for six weeks * Undergo a follow-up MRI session * Complete cognitive tests and respond to psychosocial questionnaires before, during, and after the tDCS intervention

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Female

• Over 18 years old

• Diagnosed with primary adult-onset breast cancer within the last 5 years

• Completed all active cancer treatments at least 3 months prior to study participation

• Capable of fulfilling study requirements, including having internet access.

• Fluent in either Finnish or English

• Have normal or corrected vision and hearing

• Right-handed (based on the Edinburgh Handedness Inventory score; Oldfield, 1971)

Locations
Other Locations
Finland
Department of Psychology, Faculty of Medicine, University of Helsinki
RECRUITING
Helsinki
Contact Information
Primary
Manon Chédeville, Doctoral Researcher
manon.chedeville@helsinki.fi
+358 50 326 4109
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2027-01
Participants
Target number of participants: 40
Treatments
Experimental: Active tDCS
Sham_comparator: sham tDCS
Related Therapeutic Areas
Sponsors
Leads: University of Helsinki

This content was sourced from clinicaltrials.gov

Similar Clinical Trials